Cargando…
Single-Domain Antibodies and the Promise of Modular Targeting in Cancer Imaging and Treatment
Monoclonal antibodies and their fragments have significantly changed the outcome of cancer in the clinic, effectively inhibiting tumor cell proliferation, triggering antibody-dependent immune effector cell activation and complement mediated cell death. Along with a continued expansion in number, div...
Autores principales: | Iezzi, María Elena, Policastro, Lucía, Werbajh, Santiago, Podhajcer, Osvaldo, Canziani, Gabriela Alicia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827546/ https://www.ncbi.nlm.nih.gov/pubmed/29520274 http://dx.doi.org/10.3389/fimmu.2018.00273 |
Ejemplares similares
-
Single-Domain Antibodies for Targeting, Detection, and In Vivo Imaging of Human CD4(+) Cells
por: Traenkle, Bjoern, et al.
Publicado: (2021) -
Under the Microscope: Single-Domain Antibodies for Live-Cell Imaging and Super-Resolution Microscopy
por: Traenkle, Bjoern, et al.
Publicado: (2017) -
A comparison of the binding sites of antibodies and single-domain antibodies
por: Gordon, Gemma L., et al.
Publicado: (2023) -
Camelid Single-Domain Antibodies: Historical Perspective and Future Outlook
por: Arbabi-Ghahroudi, Mehdi
Publicado: (2017) -
Editorial: Single-Domain Antibodies—Biology, Engineering and Emerging Applications
por: Henry, Kevin A., et al.
Publicado: (2018)